Published January 1, 2024 | Version v1
Journal article Open

Bio-responsive polymers for dual 31P/19F-magnetic resonance to detect reactive oxygen species in vivo

  • 1. Institut klinicke a experimentalni mediciny
  • 2. Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic
  • 3. Division of Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, Germany
  • 4. Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovskéhonám.2, Prague, Czech Republic
  • 5. Faculty ofChemical Technology, University of Chemistry and Technology, Prague, Czech Republic
  • 6. Faculty of Health Studies, Technical University of Liberec, Liberec, Czech Republic

Description

Biocompatible metal-free agents are emerging as a promising alternative to commercial magnetic resonance (MR) contrast agents, but there is an additional need for novel probes with enhanced responsiveness in preclinical MR testing to effectively target diverse pathological conditions. To address this, we develop hydrophilic phospho-/fluoropolymers as dual MR probes. Incorporating thiophosphoester groups (P = S) into the polymer structure produces a distinct chemical shift (~59 ppm) in phosphorus MR (31P-MR), reducing biological signals interference. Reactive oxygen species (ROS) oxidize the P = S groups, causing a detectable shift in 31P-MR, enabling precise localization of ROS, abundant in inflammation and cancer. To enhance this capability, bioinert trifluoromethyl groups (CF3) are added, creating a ?hotspot? for fluorine MR (19F-MR), aiding in vivo localization. Both in vitro and in vivo testing demonstrate the probe?s high specificity and responsiveness, underscoring its potential as a sensitive ROS sensor and dual MR-traceable tool in cancer research.

Notes

 ThisworkwassupportedbytheNationalInstituteforResearchofMetabolic and Cardiovascular Diseases [Program EXCELES, Project no. LX22NPO5104] founded by the European Union– NextGeneration EU program and the Ministry of Health of the Czech Republic [project no. MH CZ-DRO, Institute for Clinical and Experimental Medicine IKEM, IN 00023001], National Institute for Cancer Research (Program EXCELES, Project No. LX22NPO5102)-Funded by the European Union—Next Generation EU. We thank to Prof. Mangala Srinivas, Ph.D. (Department of Cell Biology and Immunology, Wageningen University & Research, Wageningen,TheNetherlands)forprovidingaccesstothe14Tscannerand her group memberMariah Daal, MSc for technical assistance with MR experiments. Parts ofthe Figures presented inthe Manuscript werecreated in BioRender.com.Alldatasupportingthefindingsofthisstudyareavailable within the paper and its Supplementary Information.

Files

s43246-024-00623-z.pdf

Files (1.2 MB)

Name Size Download all
md5:74ba1997198ff10c6d2d927f8973e753
1.2 MB Preview Download

Additional details

Related works

Is part of
2662-4443 (ISSN)
2662-4443 (ISSN)
References
10.1038/s43246-024-00623-z (DOI)